These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 8572637

  • 1. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
    Eskelinen M, Lipponen P, Nordling S.
    Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE, Veys JA, Eskridge MR, Woodruff RD, Hall MC.
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [Abstract] [Full Text] [Related]

  • 3. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L, Bouchet C, Cesari D, Uzan S, Lefranc JP, Antoine M, Genestie C, Deniaud-Alexandre E, Bernaudin JF, Touboul E, Fleury-Feith J.
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [Abstract] [Full Text] [Related]

  • 4. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L, Bouchet C, Cesari D, Uzan S, Lefranc JP, Antoine M, Genestie C, Deniaud-Alexandre E, Bernaudin JF, Touboul E, Fleury-Feith J.
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [Abstract] [Full Text] [Related]

  • 5. Flow cytometric DNA and cytomorphometric analysis in renal cell carcinoma: its correlation with histopathology and prognosis.
    Yu DS, Hsu CM, Lee WH, Chang SY, Ma CP.
    J Surg Res; 1993 Nov; 55(5):480-5. PubMed ID: 8231166
    [Abstract] [Full Text] [Related]

  • 6. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P.
    Scand J Urol Nephrol Suppl; 1994 Nov; 165():1-48. PubMed ID: 7871395
    [Abstract] [Full Text] [Related]

  • 7. DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer.
    Lipponen P, Papinaho S, Eskelinen M, Klemi PJ, Aaltomaa S, Kosma VM, Marin S, Syrjänen K.
    Anticancer Res; 1992 Nov; 12(5):1533-8. PubMed ID: 1444217
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma.
    Chautard D, Dalifard I, Chassevent A, Guyetant S, Daver A, Vielle B, Soret JY.
    Urology; 2004 Jun; 63(6):1055-60. PubMed ID: 15183949
    [Abstract] [Full Text] [Related]

  • 9. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
    Abou-Rebyeh H, Borgmann V, Nagel R, Al-Abadi H.
    Cancer; 2001 Nov 01; 92(9):2280-5. PubMed ID: 11745282
    [Abstract] [Full Text] [Related]

  • 10. [Significance of flow cytometry in the prognosis of tumors of the kidney in adults].
    Sibert L, Laquerrière A, Czernichow P, Dadoun D, Hemet J, Grise P.
    Ann Urol (Paris); 1989 Nov 01; 23(6):476-81. PubMed ID: 2694924
    [Abstract] [Full Text] [Related]

  • 11. [Study of the prognostic value of DNA ploidy and proliferation index (Ki-67) in renal cell carcinoma with venous thrombus].
    Rey D, Pfister C, Gobet F, Martinez S, Staerman F, Grise P.
    Prog Urol; 2003 Dec 01; 13(6):1300-6. PubMed ID: 15000303
    [Abstract] [Full Text] [Related]

  • 12. [Renal cell carcinoma: DNA cytometry and its clinical significance. An 8 year survival study].
    al-Abadi H, Nagel R.
    Helv Chir Acta; 1991 Sep 01; 58(3):331-4. PubMed ID: 1769855
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma.
    Pfisterer J, Kommoss F, Sauerbrei W, Rendl I, Kiechle M, Kleine W, Pfleiderer A.
    Gynecol Oncol; 1995 Aug 01; 58(2):149-56. PubMed ID: 7622098
    [Abstract] [Full Text] [Related]

  • 14. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
    del Vecchio MT, Lazzi S, Bruni A, Mangiavacchi P, Cevenini G, Luzi P.
    Pathol Res Pract; 1998 Aug 01; 194(5):325-33. PubMed ID: 9651945
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of cellular proliferation in renal cell carcinoma: a comparison of synthesis-phase fraction and proliferating cell nuclear antigen index.
    Grignon DJ, Abdel-Malak M, Mertens W, Koster J, Keeney M, Sakr W, Shepherd RR.
    Mod Pathol; 1995 Jan 01; 8(1):18-24. PubMed ID: 7731937
    [Abstract] [Full Text] [Related]

  • 16. Classic prognostic factors, flow cytometric data, nuclear morphometric variables and mitotic indexes as predictors in transitional cell bladder cancer.
    Lipponen PK, Eskelinen MJ, Kiviranta J, Nordling S.
    Anticancer Res; 1991 Jan 01; 11(2):911-6. PubMed ID: 2064350
    [Abstract] [Full Text] [Related]

  • 17. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G, Lindholm K, Falkmer U, Abrahamsson PA.
    Urology; 1997 Sep 01; 50(3):379-84. PubMed ID: 9301701
    [Abstract] [Full Text] [Related]

  • 18. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
    Ljungberg B.
    Scand J Urol Nephrol Suppl; 1986 Sep 01; 100():1-47. PubMed ID: 3472340
    [Abstract] [Full Text] [Related]

  • 19. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator.
    Hsu MM, Chiou CR, Ko JY, Sheen TS, Hong RL, Ting LL.
    Cancer Detect Prev; 2000 Sep 01; 24(2):119-26. PubMed ID: 10917131
    [Abstract] [Full Text] [Related]

  • 20. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
    Belessi CJ, Parasi AS, Manioudaki HS, Laoutaris NP, Legakis NC, Peros GT, Androulakis GA.
    J Surg Oncol; 2003 Apr 01; 82(4):247-55. PubMed ID: 12672009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.